Introduction. Hemophilia is a major public health concern among rare diseases, prompting the active involvement of international organizations. Less than half of patients have a confirmed diagnosis, highlighting a significant degree of underdiagnosis, especially in resource-limited countries.
The aim of the research was to study the clinical manifestations and genetic profile of hemophilia in children, for improving the accuracy of diagnosis and developing a personalized therapeutic model appropriate to the form and severity.
Materials and methods. An observational, descriptive, cross-sectional study with specific participant selection included a group of 90 children aged between 0 and 18 years. The coding and flanking regions of F8/F9 were amplified and analyzed by heteroduplex and automatic sequencing (Genetic Analyzer 3100).
Results. In terms of clinical severity, severe hemophilia A was the most common (48.9%), followed by moderate (36.7%) and mild (14.4%). In severe forms, six joints were affected in 13.6% of cases. The most common mutation identified in the total patient group was the Missense mutation, followed by Inversion of intron 22 and Frameshift. In the group with no inhibitors, most patients had unknown genetic status (94.6%), and Missense and Frameshift mutations were present in a small proportion (2.7% each). The database created allows physicians access to both current and historical data.
Conclusions. The findings support the improvement of pediatric hemophilia approach. Continuous monitoring and adequate management planning will reduce the patient’s disability risks and increase their life quality.
Keywords: hemophilia, registry, children, inhibitors, severity.
Address for correspondence:
Vladimir IACOMI
Address: Department of Pediatrics, Nicolae Testemitanu State University of Medicine
and Pharmacy, Chisinau, Republic of Moldova
Email: vladimir.iacomi@usmf.md;
Phone: +373 68080995